Next Catalyst, page-31

First 31 Last

Share
Profile

Follow
Orioles

327 Posts.

7

17/03/18

10:29

Post #: 31825360
Share

Originally posted by markco2 ↑

Dmacd,

Welcome to HC.

I don't believe the market was displeased with the way it was done, unless of course it was the short term stock holders who clearly can't see the wood from the trees. The only issue I can see was the free attaching options that automatically put them in the money. Maybe that could have been done better.

Management's plan is to showcase Immuron and strike a couple of partnerships without diluting the crap out of Immuron any further.

That has ballooned over the years with placement after placement with little in return.
What we have now is a company that has grown its asset base and built upon the Travelan Trademark along with long standing partnerships conducting the various trials and studies. It is only now that Immurons potential is starting to be realised. It was in 2009 when Hadassah first discovered a treatment in Fatty Liver Disease using Immurons Colostrum enriched with insulin antibodies, that showed Immuron was clearly onto something special.

If Immurons management felt that they needed more placement funds to see them through they would have gone for it. They obviously don't see the need.
If that is the case, expect partnerships to be formed and deals to be struck not too far down the track.

Expand

Excellent analysis as always. I agree 100%.

IMC Price at posting: 41.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

AS2

Nejo approvals the trigger for Askari Metals as maiden Ethiopian campaign looms

KLV

Klevo Rewards advances stablecoin strategy with credit licence acquisition

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

DBO

Diablo expands critical minerals footprint at Star Range

KAO

Kaoko Metals begins Chalkos drilling

AFP

AFT Pharmaceutical's multi-billion R&D opportunity

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

PL9

Prairie Lithium advances towards first production as commercial DLE unit arrives

FRX

Flexiroam partners with Etihad Airways to accelerate enterprise growth

14D

1414 Degrees: Inside the SiNTL battery pivot to drones, defence

First 31 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 3.2¢		Change 0.000(0.00%)		Mkt cap ! $10.45M

Open	High	Low	Volume
0.0¢	0.0¢	0.0¢	0

Buyers (Bids)

Vol.	Price($)
57122	3.3¢

Sellers (Offers)

Price($)	Vol.
3.6¢	39734

Last trade - 11.13am 07/08/2026 (20 minute delay)

IMC (ASX) Chart

Day chart unavailable

Next Catalyst, page-31

Top Stories

Nejo approvals the trigger for Askari Metals as maiden Ethiopian campaign looms

Klevo Rewards advances stablecoin strategy with credit licence acquisition

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

Diablo expands critical minerals footprint at Star Range

Kaoko Metals begins Chalkos drilling

AFT Pharmaceutical's multi-billion R&D opportunity

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

Prairie Lithium advances towards first production as commercial DLE unit arrives

Flexiroam partners with Etihad Airways to accelerate enterprise growth

1414 Degrees: Inside the SiNTL battery pivot to drones, defence

Buyers (Bids)

Sellers (Offers)